1
|
Lyakhova UA, Lyakhov PA. Systematic review of approaches to detection and classification of skin cancer using artificial intelligence: Development and prospects. Comput Biol Med 2024; 178:108742. [PMID: 38875908 DOI: 10.1016/j.compbiomed.2024.108742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2024] [Revised: 06/03/2024] [Accepted: 06/08/2024] [Indexed: 06/16/2024]
Abstract
In recent years, there has been a significant improvement in the accuracy of the classification of pigmented skin lesions using artificial intelligence algorithms. Intelligent analysis and classification systems are significantly superior to visual diagnostic methods used by dermatologists and oncologists. However, the application of such systems in clinical practice is severely limited due to a lack of generalizability and risks of potential misclassification. Successful implementation of artificial intelligence-based tools into clinicopathological practice requires a comprehensive study of the effectiveness and performance of existing models, as well as further promising areas for potential research development. The purpose of this systematic review is to investigate and evaluate the accuracy of artificial intelligence technologies for detecting malignant forms of pigmented skin lesions. For the study, 10,589 scientific research and review articles were selected from electronic scientific publishers, of which 171 articles were included in the presented systematic review. All selected scientific articles are distributed according to the proposed neural network algorithms from machine learning to multimodal intelligent architectures and are described in the corresponding sections of the manuscript. This research aims to explore automated skin cancer recognition systems, from simple machine learning algorithms to multimodal ensemble systems based on advanced encoder-decoder models, visual transformers (ViT), and generative and spiking neural networks. In addition, as a result of the analysis, future directions of research, prospects, and potential for further development of automated neural network systems for classifying pigmented skin lesions are discussed.
Collapse
Affiliation(s)
- U A Lyakhova
- Department of Mathematical Modeling, North-Caucasus Federal University, 355017, Stavropol, Russia.
| | - P A Lyakhov
- Department of Mathematical Modeling, North-Caucasus Federal University, 355017, Stavropol, Russia; North-Caucasus Center for Mathematical Research, North-Caucasus Federal University, 355017, Stavropol, Russia.
| |
Collapse
|
2
|
Ahuja KR, Lio P. Does internal validity play a factor in ChatGPT's success? Clin Exp Dermatol 2024; 49:931-932. [PMID: 38494627 DOI: 10.1093/ced/llae087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2023] [Revised: 01/16/2024] [Accepted: 03/14/2024] [Indexed: 03/19/2024]
Abstract
We elaborated on our previously published article by asking ChatGPT to create images for each of the diagnoses previously asked in our article. We assessed ChatGPT’s internal validity by calculating the accuracy of the responses provided to its own images.
Collapse
Affiliation(s)
| | - Peter Lio
- Northwestern University, Department of Dermatology, Chicago, IL, USA
| |
Collapse
|
3
|
Subramanian T, Araghi K, Amen TB, Kaidi A, Sosa B, Shahi P, Qureshi S, Iyer S. Chat Generative Pretraining Transformer Answers Patient-focused Questions in Cervical Spine Surgery. Clin Spine Surg 2024; 37:E278-E281. [PMID: 38531823 DOI: 10.1097/bsd.0000000000001600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Accepted: 11/29/2023] [Indexed: 03/28/2024]
Abstract
STUDY DESIGN Review of Chat Generative Pretraining Transformer (ChatGPT) outputs to select patient-focused questions. OBJECTIVE We aimed to examine the quality of ChatGPT responses to cervical spine questions. BACKGROUND Artificial intelligence and its utilization to improve patient experience across medicine is seeing remarkable growth. One such usage is patient education. For the first time on a large scale, patients can ask targeted questions and receive similarly targeted answers. Although patients may use these resources to assist in decision-making, there still exists little data regarding their accuracy, especially within orthopedic surgery and more specifically spine surgery. METHODS We compiled 9 frequently asked questions cervical spine surgeons receive in the clinic to test ChatGPT's version 3.5 ability to answer a nuanced topic. Responses were reviewed by 2 independent reviewers on a Likert Scale for the accuracy of information presented (0-5 points), appropriateness in giving a specific answer (0-3 points), and readability for a layperson (0-2 points). Readability was assessed through the Flesh-Kincaid grade level analysis for the original prompt and for a second prompt asking for rephrasing at the sixth-grade reading level. RESULTS On average, ChatGPT's responses scored a 7.1/10. Accuracy was rated on average a 4.1/5. Appropriateness was 1.8/3. Readability was a 1.2/2. Readability was determined to be at the 13.5 grade level originally and at the 11.2 grade level after prompting. CONCLUSIONS ChatGPT has the capacity to be a powerful means for patients to gain important and specific information regarding their pathologies and surgical options. These responses are limited in their accuracy, and we, in addition, noted readability is not optimal for the average patient. Despite these limitations in ChatGPT's capability to answer these nuanced questions, the technology is impressive, and surgeons should be aware patients will likely increasingly rely on it.
Collapse
Affiliation(s)
- Tejas Subramanian
- Department of Orthopedic Surgery, Hospital for Special Surgery
- Weill Cornell Medicine, New York, NY
| | - Kasra Araghi
- Department of Orthopedic Surgery, Hospital for Special Surgery
| | - Troy B Amen
- Department of Orthopedic Surgery, Hospital for Special Surgery
| | - Austin Kaidi
- Department of Orthopedic Surgery, Hospital for Special Surgery
| | | | - Pratyush Shahi
- Department of Orthopedic Surgery, Hospital for Special Surgery
| | - Sheeraz Qureshi
- Department of Orthopedic Surgery, Hospital for Special Surgery
- Weill Cornell Medicine, New York, NY
| | - Sravisht Iyer
- Department of Orthopedic Surgery, Hospital for Special Surgery
- Weill Cornell Medicine, New York, NY
| |
Collapse
|
4
|
Albaladejo A, Lorleac'h A, Allain JS. [The spring of artificial intelligence: AI vs. expert for internal medicine cases]. Rev Med Interne 2024; 45:409-414. [PMID: 38331591 DOI: 10.1016/j.revmed.2024.01.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Revised: 01/09/2024] [Accepted: 01/17/2024] [Indexed: 02/10/2024]
Abstract
INTRODUCTION The "Printemps de la Médecine Interne" are training days for Francophone internists. The clinical cases presented during these days are complex. This study aims to evaluate the diagnostic capabilities of non-specialized artificial intelligence (language models) ChatGPT-4 and Bard by confronting them with the puzzles of the "Printemps de la Médecine Interne". METHOD Clinical cases from the "Printemps de la Médecine Interne" 2021 and 2022 were submitted to two language models: ChatGPT-4 and Bard. In case of a wrong answer, a second attempt was offered. We then compared the responses of human internist experts to those of artificial intelligence. RESULTS Of the 12 clinical cases submitted, human internist experts diagnosed nine, ChatGPT-4 diagnosed three, and Bard diagnosed one. One of the cases solved by ChatGPT-4 was not solved by the internist expert. The artificial intelligence had a response time of a few seconds. CONCLUSIONS Currently, the diagnostic skills of ChatGPT-4 and Bard are inferior to those of human experts in solving complex clinical cases but are very promising. Recently made available to the general public, they already have impressive capabilities, questioning the role of the diagnostic physician. It would be advisable to adapt the rules or subjects of future "Printemps de la Médecine Interne" so that they are not solved by a public language model.
Collapse
Affiliation(s)
- A Albaladejo
- Médecine interne et immunologie clinique, CHU de Rennes, 2, rue Henri-le-Guilloux, 35000 Rennes, France.
| | - A Lorleac'h
- Groupement hospitalier Bretagne Sud, 5, avenue Choiseul, 56100 Lorient, France.
| | - J-S Allain
- Groupement hospitalier Bretagne Sud, 5, avenue Choiseul, 56100 Lorient, France.
| |
Collapse
|
5
|
Lewandowski M, Łukowicz P, Świetlik D, Barańska-Rybak W. ChatGPT-3.5 and ChatGPT-4 dermatological knowledge level based on the Specialty Certificate Examination in Dermatology. Clin Exp Dermatol 2024; 49:686-691. [PMID: 37540015 DOI: 10.1093/ced/llad255] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2023] [Revised: 07/17/2023] [Accepted: 07/31/2023] [Indexed: 08/05/2023]
Abstract
BACKGROUND The global use of artificial intelligence (AI) has the potential to revolutionize the healthcare industry. Despite the fact that AI is becoming more popular, there is still a lack of evidence on its use in dermatology. OBJECTIVES To determine the capacity of ChatGPT-3.5 and ChatGPT-4 to support dermatology knowledge and clinical decision-making in medical practice. METHODS Three Specialty Certificate Examination in Dermatology tests, in English and Polish, consisting of 120 single-best-answer, multiple-choice questions each, were used to assess the performance of ChatGPT-3.5 and ChatGPT-4. RESULTS ChatGPT-4 exceeded the 60% pass rate in every performed test, with a minimum of 80% and 70% correct answers for the English and Polish versions, respectively. ChatGPT-4 performed significantly better on each exam (P < 0.01), regardless of language, compared with ChatGPT-3.5. Furthermore, ChatGPT-4 answered clinical picture-type questions with an average accuracy of 93.0% and 84.2% for questions in English and Polish, respectively. The difference between the tests in Polish and English were not significant; however, ChatGPT-3.5 and ChatGPT-4 performed better overall in English than in Polish by an average of 8 percentage points for each test. Incorrect ChatGPT answers were highly correlated with a lower difficulty index, denoting questions of higher difficulty in most of the tests (P < 0.05). CONCLUSIONS The dermatology knowledge level of ChatGPT was high, and ChatGPT-4 performed significantly better than ChatGPT-3.5. Although the use of ChatGPT will not replace a doctor's final decision, physicians should support the development of AI in dermatology to raise the standards of medical care.
Collapse
Affiliation(s)
- Miłosz Lewandowski
- Department of Dermatology, Venereology and Allergology, Faculty of Medicine
| | - Paweł Łukowicz
- Division of Biostatistics and Neural Networks, Medical University of Gdansk, Gdansk, Poland
| | - Dariusz Świetlik
- Division of Biostatistics and Neural Networks, Medical University of Gdansk, Gdansk, Poland
| | | |
Collapse
|
6
|
Long BV. Artificial Intelligence Useful in the Practice of Geriatric Dermatology? Clin Dermatol 2024:S0738-081X(24)00096-8. [PMID: 38936640 DOI: 10.1016/j.clindermatol.2024.06.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/29/2024]
Abstract
Geriatric dermatology has risen in importance through the years, alongside a steadily ageing global population. Simultaneously, artificial intelligence (AI) technologies have become more advanced, and AI has been found to be useful in the general practice of dermatology. Whether or not, and how AI can be useful in the practice of geriatric dermatology remains unanswered. We explore the intricacies and potential roles AI can play in the practice of geriatric dermatology and recommend that physicians should recognize the tremendous potential of AI, in terms of facilitating diagnoses of disease, guiding and personalizing therapeutics and even expanding therapeutic options, whilst remaining cautious about AI's current pitfalls and acceptability amongst its elderly audience.
Collapse
Affiliation(s)
- By Valencia Long
- Department of Medicine, National University Hospital, National University Health System, Singapore.
| |
Collapse
|
7
|
Ahuja K, DeSena G, Lio P. Evaluation of dermatological conditions: the diagnostic potential of artificial intelligence in primary care. Clin Exp Dermatol 2024; 49:737-739. [PMID: 38039141 DOI: 10.1093/ced/llad423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Accepted: 11/29/2023] [Indexed: 12/03/2023]
Abstract
We used publicly available images to determine ChatGPT’s diagnostic accuracy and potential to aid in primary care diagnostics of dermatological conditions. We found a lower diagnostic accuracy with publicly available images than with patient images, demonstrating that digital transparency and image retrieval play no role in ChatGPT’s diagnostic accuracy.
Collapse
Affiliation(s)
- Kripa Ahuja
- Eastern Virginia Medical School, Norfolk, VA, USA
| | - Grace DeSena
- University of Florida College of Medicine, Gainesville, FL, USA
| | - Peter Lio
- Northwestern University, Department of Dermatology, Chicago, IL, USA
| |
Collapse
|
8
|
Sohail N, Puyana C, Zimmerman L, Tsoukas MM. AI in Dermatology: Bridging the Gap in Patient Care and Education. Clin Dermatol 2024:S0738-081X(24)00093-2. [PMID: 38936639 DOI: 10.1016/j.clindermatol.2024.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/29/2024]
Abstract
The application of Artificial Intelligence (AI) in education and clinical medicine has shown tremendous growth. The primary explanation for this application is due to AI's ability to integrate efficient and tailored methods for screening, utilizing diagnostics, as well as enhancement of patient and medical education. AI's wide scope of utility can be seen through its ability to improve efficiency in clinical settings through scheduling, charting, diagnostics and screening tools, ultimately allowing for physicians to be able to spend more focused time on patient care. AI has also shown a tangible impact on promoting patient education through its ability to provide patients with preliminary information regarding their diagnoses, prior to follow-up and further discussion with their physician. Similarly, AI's application in medical education has shown to be promising due to its ability to provide immediate and interactive feedback to the learner, which allows for meaningful reinforcement of knowledge. Through all of this, AI can be recognized as a tool that can provide incredible enhancement in the areas of clinical medicine and education, with meaningful opportunities for integration and application.
Collapse
Affiliation(s)
- Nayyab Sohail
- Department of Dermatology, University of Illinois College of Medicine at Chicago, Chicago, Illinois
| | - Carolina Puyana
- Department of Dermatology, University of Illinois College of Medicine at Chicago, Chicago, Illinois
| | - Lacey Zimmerman
- Department of Dermatology, University of Illinois College of Medicine at Chicago, Chicago, Illinois
| | - Maria M Tsoukas
- Department of Dermatology, University of Illinois College of Medicine at Chicago, Chicago, Illinois.
| |
Collapse
|
9
|
Trager MH, Gordon ER, Breneman A, Weng C, Samie FH. Artificial intelligence for nonmelanoma skin cancer. Clin Dermatol 2024:S0738-081X(24)00100-7. [PMID: 38925444 DOI: 10.1016/j.clindermatol.2024.06.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/28/2024]
Abstract
Nonmelanoma skin cancers (NMSCs) are among the top five most common cancers globally. NMSC is an area with great potential for novel application of diagnostic tools including artificial intelligence (AI). In this scoping review, we aimed to describe the applications of AI in the diagnosis and treatment of NMSC. Twenty-nine publications described AI applications to dermatopathology including lesion classification and margin assessment. Twenty-five publications discussed AI use in clinical image analysis, showing that algorithms are not superior to dermatologists and may rely on unbalanced, nonrepresentative, and nontransparent training data sets. Sixteen publications described the use of AI in cutaneous surgery for NMSC including use in margin assessment during excisions and Mohs surgery, as well as predicting procedural complexity. Eleven publications discussed spectroscopy, confocal microscopy, thermography, and the AI algorithms that analyze and interpret their data. Ten publications pertained to AI applications for the discovery and use of NMSC biomarkers. Eight publications discussed the use of smartphones and AI, specifically how they enable clinicians and patients to have increased access to instant dermatologic assessments but with varying accuracies. Five publications discussed large language models and NMSC, including how they may facilitate or hinder patient education and medical decision-making. Three publications pertaining to the skin of color and AI for NMSC discussed concerns regarding limited diverse data sets for the training of convolutional neural networks. AI demonstrates tremendous potential to improve diagnosis, patient and clinician education, and management of NMSC. Despite excitement regarding AI, data sets are often not transparently reported, may include low-quality images, and may not include diverse skin types, limiting generalizability. AI may serve as a tool to increase access to dermatology services for patients in rural areas and save health care dollars. These benefits can only be achieved, however, with consideration of potential ethical costs.
Collapse
Affiliation(s)
- Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Emily R Gordon
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
| | - Alyssa Breneman
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Chunhua Weng
- Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
| |
Collapse
|
10
|
Perrin J, Petronic-Rosic V. The Potential Role and Restrictions of AI in Medical School Dermatology Education. Clin Dermatol 2024:S0738-081X(24)00101-9. [PMID: 38925446 DOI: 10.1016/j.clindermatol.2024.06.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/28/2024]
Abstract
Artificial intelligence (AI) is a rapidly developing field with the potential to transform various aspects of health care and public health, including medical training. The utility of AI is still being studied to understand better how to integrate its innumerable applications into modern medicine and how it is taught. Medical school dermatology education in particular stands to benefit from AI, especially when considering medical schools that lack dermatology curriculums. In this review, we evaluate the integration of AI technology in the field of dermatology and how it can inform how dermatology is taught in medical schools across the United States.
Collapse
Affiliation(s)
| | - Vesna Petronic-Rosic
- University of Illinois College of Medicine, Chicago, IL; Division of Dermatology, Department of Medicine, Cook County Health, Chicago, IL.
| |
Collapse
|
11
|
Papachristou P, Söderholm M, Pallon J, Taloyan M, Polesie S, Paoli J, Anderson CD, Falk M. Evaluation of an artificial intelligence-based decision support for the detection of cutaneous melanoma in primary care: a prospective real-life clinical trial. Br J Dermatol 2024; 191:125-133. [PMID: 38234043 DOI: 10.1093/bjd/ljae021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2023] [Revised: 01/12/2024] [Accepted: 01/13/2024] [Indexed: 01/19/2024]
Abstract
BACKGROUND Use of artificial intelligence (AI), or machine learning, to assess dermoscopic images of skin lesions to detect melanoma has, in several retrospective studies, shown high levels of diagnostic accuracy on par with - or even outperforming - experienced dermatologists. However, the enthusiasm around these algorithms has not yet been matched by prospective clinical trials performed in authentic clinical settings. In several European countries, including Sweden, the initial clinical assessment of suspected skin cancer is principally conducted in the primary healthcare setting by primary care physicians, with or without access to teledermoscopic support from dermatology clinics. OBJECTIVES To determine the diagnostic performance of an AI-based clinical decision support tool for cutaneous melanoma detection, operated by a smartphone application (app), when used prospectively by primary care physicians to assess skin lesions of concern due to some degree of melanoma suspicion. METHODS This prospective multicentre clinical trial was conducted at 36 primary care centres in Sweden. Physicians used the smartphone app on skin lesions of concern by photographing them dermoscopically, which resulted in a dichotomous decision support text regarding evidence for melanoma. Regardless of the app outcome, all lesions underwent standard diagnostic procedures (surgical excision or referral to a dermatologist). After investigations were complete, lesion diagnoses were collected from the patients' medical records and compared with the app's outcome and other lesion data. RESULTS In total, 253 lesions of concern in 228 patients were included, of which 21 proved to be melanomas, with 11 thin invasive melanomas and 10 melanomas in situ. The app's accuracy in identifying melanomas was reflected in an area under the receiver operating characteristic (AUROC) curve of 0.960 [95% confidence interval (CI) 0.928-0.980], corresponding to a maximum sensitivity and specificity of 95.2% and 84.5%, respectively. For invasive melanomas alone, the AUROC was 0.988 (95% CI 0.965-0.997), corresponding to a maximum sensitivity and specificity of 100% and 92.6%, respectively. CONCLUSIONS The clinical decision support tool evaluated in this investigation showed high diagnostic accuracy when used prospectively in primary care patients, which could add significant clinical value for primary care physicians assessing skin lesions for melanoma.
Collapse
Affiliation(s)
- Panagiotis Papachristou
- Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
- Atrium Healthcare Centre, Region Stockholm, Sweden
| | - My Söderholm
- Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
- Ekholmen Primary Healthcare Centre, Region Östergötland, Linköping, Sweden
| | - Jon Pallon
- Department of Clinical Sciences in Malmö, Family Medicine, Lund University, Malmö, Sweden
- Department of Research and Development, Region Kronoberg, Växjö, Sweden
| | - Marina Taloyan
- Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
- Atrium Healthcare Centre, Region Stockholm, Sweden
| | - Sam Polesie
- Region Västra Götaland, Sahlgrenska University Hospital, Department of Dermatology and Venereology, Gothenburg, Sweden
- Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - John Paoli
- Region Västra Götaland, Sahlgrenska University Hospital, Department of Dermatology and Venereology, Gothenburg, Sweden
- Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Chris D Anderson
- Department of Biomedical and Clinical Sciences, Division of Dermatology and Venereology, Linköping University, Linköping, Sweden
| | - Magnus Falk
- Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
- Region Östergötland, Kärna Primary Healthcare Centre, Linköping, Sweden
| |
Collapse
|
12
|
Khatun N, Spinelli G, Colecchia F. Technology innovation to reduce health inequality in skin diagnosis and to improve patient outcomes for people of color: a thematic literature review and future research agenda. Front Artif Intell 2024; 7:1394386. [PMID: 38938325 PMCID: PMC11209749 DOI: 10.3389/frai.2024.1394386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Accepted: 05/27/2024] [Indexed: 06/29/2024] Open
Abstract
The health inequalities experienced by ethnic minorities have been a persistent and global phenomenon. The diagnosis of different types of skin conditions, e.g., melanoma, among people of color is one of such health domains where misdiagnosis can take place, potentially leading to life-threatening consequences. Although Caucasians are more likely to be diagnosed with melanoma, African Americans are four times more likely to present stage IV melanoma due to delayed diagnosis. It is essential to recognize that additional factors such as socioeconomic status and limited access to healthcare services can be contributing factors. African Americans are also 1.5 times more likely to die from melanoma than Caucasians, with 5-year survival rates for African Americans significantly lower than for Caucasians (72.2% vs. 89.6%). This is a complex problem compounded by several factors: ill-prepared medical practitioners, lack of awareness of melanoma and other skin conditions among people of colour, lack of information and medical resources for practitioners' continuous development, under-representation of people of colour in research, POC being a notoriously hard to reach group, and 'whitewashed' medical school curricula. Whilst digital technology can bring new hope for the reduction of health inequality, the deployment of artificial intelligence in healthcare carries risks that may amplify the health disparities experienced by people of color, whilst digital technology may provide a false sense of participation. For instance, Derm Assist, a skin diagnosis phone application which is under development, has already been criticized for relying on data from a limited number of people of color. This paper focuses on understanding the problem of misdiagnosing skin conditions in people of color and exploring the progress and innovations that have been experimented with, to pave the way to the possible application of big data analytics, artificial intelligence, and user-centred technology to reduce health inequalities among people of color.
Collapse
Affiliation(s)
| | - Gabriella Spinelli
- College of Engineering, Design and Physical Science, Brunel Design School, Brunel University London, Uxbridge, United Kingdom
| | | |
Collapse
|
13
|
Seoni S, Shahini A, Meiburger KM, Marzola F, Rotunno G, Acharya UR, Molinari F, Salvi M. All you need is data preparation: A systematic review of image harmonization techniques in Multi-center/device studies for medical support systems. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2024; 250:108200. [PMID: 38677080 DOI: 10.1016/j.cmpb.2024.108200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2024] [Revised: 04/20/2024] [Accepted: 04/22/2024] [Indexed: 04/29/2024]
Abstract
BACKGROUND AND OBJECTIVES Artificial intelligence (AI) models trained on multi-centric and multi-device studies can provide more robust insights and research findings compared to single-center studies. However, variability in acquisition protocols and equipment can introduce inconsistencies that hamper the effective pooling of multi-source datasets. This systematic review evaluates strategies for image harmonization, which standardizes appearances to enable reliable AI analysis of multi-source medical imaging. METHODS A literature search using PRISMA guidelines was conducted to identify relevant papers published between 2013 and 2023 analyzing multi-centric and multi-device medical imaging studies that utilized image harmonization approaches. RESULTS Common image harmonization techniques included grayscale normalization (improving classification accuracy by up to 24.42 %), resampling (increasing the percentage of robust radiomics features from 59.5 % to 89.25 %), and color normalization (enhancing AUC by up to 0.25 in external test sets). Initially, mathematical and statistical methods dominated, but machine and deep learning adoption has risen recently. Color imaging modalities like digital pathology and dermatology have remained prominent application areas, though harmonization efforts have expanded to diverse fields including radiology, nuclear medicine, and ultrasound imaging. In all the modalities covered by this review, image harmonization improved AI performance, with increasing of up to 24.42 % in classification accuracy and 47 % in segmentation Dice scores. CONCLUSIONS Continued progress in image harmonization represents a promising strategy for advancing healthcare by enabling large-scale, reliable analysis of integrated multi-source datasets using AI. Standardizing imaging data across clinical settings can help realize personalized, evidence-based care supported by data-driven technologies while mitigating biases associated with specific populations or acquisition protocols.
Collapse
Affiliation(s)
- Silvia Seoni
- Biolab, PolitoBIOMedLab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
| | - Alen Shahini
- Biolab, PolitoBIOMedLab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
| | - Kristen M Meiburger
- Biolab, PolitoBIOMedLab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
| | - Francesco Marzola
- Biolab, PolitoBIOMedLab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
| | - Giulia Rotunno
- Biolab, PolitoBIOMedLab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
| | - U Rajendra Acharya
- School of Mathematics, Physics and Computing, University of Southern Queensland, Springfield, Australia; Centre for Health Research, University of Southern Queensland, Australia
| | - Filippo Molinari
- Biolab, PolitoBIOMedLab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
| | - Massimo Salvi
- Biolab, PolitoBIOMedLab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy.
| |
Collapse
|
14
|
Gordon ER, Trager MH, Kontos D, Weng C, Geskin LJ, Dugdale LS, Samie FH. Ethical considerations for artificial intelligence in dermatology: a scoping review. Br J Dermatol 2024; 190:789-797. [PMID: 38330217 DOI: 10.1093/bjd/ljae040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 12/26/2023] [Accepted: 01/23/2024] [Indexed: 02/10/2024]
Abstract
The field of dermatology is experiencing the rapid deployment of artificial intelligence (AI), from mobile applications (apps) for skin cancer detection to large language models like ChatGPT that can answer generalist or specialist questions about skin diagnoses. With these new applications, ethical concerns have emerged. In this scoping review, we aimed to identify the applications of AI to the field of dermatology and to understand their ethical implications. We used a multifaceted search approach, searching PubMed, MEDLINE, Cochrane Library and Google Scholar for primary literature, following the PRISMA Extension for Scoping Reviews guidance. Our advanced query included terms related to dermatology, AI and ethical considerations. Our search yielded 202 papers. After initial screening, 68 studies were included. Thirty-two were related to clinical image analysis and raised ethical concerns for misdiagnosis, data security, privacy violations and replacement of dermatologist jobs. Seventeen discussed limited skin of colour representation in datasets leading to potential misdiagnosis in the general population. Nine articles about teledermatology raised ethical concerns, including the exacerbation of health disparities, lack of standardized regulations, informed consent for AI use and privacy challenges. Seven addressed inaccuracies in the responses of large language models. Seven examined attitudes toward and trust in AI, with most patients requesting supplemental assessment by a physician to ensure reliability and accountability. Benefits of AI integration into clinical practice include increased patient access, improved clinical decision-making, efficiency and many others. However, safeguards must be put in place to ensure the ethical application of AI.
Collapse
Affiliation(s)
- Emily R Gordon
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
| | - Megan H Trager
- Columbia University Irving Medical Center, Departments of Dermatology
| | - Despina Kontos
- University of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, PA, USA
- Radiology
| | | | - Larisa J Geskin
- Columbia University Irving Medical Center, Departments of Dermatology
| | - Lydia S Dugdale
- Columbia University Vagelos College of Physicians and Surgeons, Department of Medicine, Center for Clinical Medical Ethics, New York, NY, USA
| | - Faramarz H Samie
- Columbia University Irving Medical Center, Departments of Dermatology
| |
Collapse
|
15
|
Andersson E, Hult J, Troein C, Stridh M, Sjögren B, Pekar-Lukacs A, Hernandez-Palacios J, Edén P, Persson B, Olariu V, Malmsjö M, Merdasa A. Facilitating clinically relevant skin tumor diagnostics with spectroscopy-driven machine learning. iScience 2024; 27:109653. [PMID: 38680659 PMCID: PMC11053315 DOI: 10.1016/j.isci.2024.109653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Revised: 03/26/2024] [Accepted: 04/01/2024] [Indexed: 05/01/2024] Open
Abstract
In the dawning era of artificial intelligence (AI), health care stands to undergo a significant transformation with the increasing digitalization of patient data. Digital imaging, in particular, will serve as an important platform for AI to aid decision making and diagnostics. A growing number of studies demonstrate the potential of automatic pre-surgical skin tumor delineation, which could have tremendous impact on clinical practice. However, current methods rely on having ground truth images in which tumor borders are already identified, which is not clinically possible. We report a novel approach where hyperspectral images provide spectra from small regions representing healthy tissue and tumor, which are used to generate prediction maps using artificial neural networks (ANNs), after which a segmentation algorithm automatically identifies the tumor borders. This circumvents the need for ground truth images, since an ANN model is trained with data from each individual patient, representing a more clinically relevant approach.
Collapse
Affiliation(s)
- Emil Andersson
- Centre for Environmental and Climate Science, Lund University, Lund, Sweden
| | - Jenny Hult
- Department of Clinical Sciences Lund, Ophthalmology, Lund University, Lund, Sweden
| | - Carl Troein
- Centre for Environmental and Climate Science, Lund University, Lund, Sweden
| | - Magne Stridh
- Department of Clinical Sciences Lund, Ophthalmology, Lund University, Lund, Sweden
| | - Benjamin Sjögren
- Department of Clinical Sciences Lund, Ophthalmology, Lund University, Lund, Sweden
| | | | | | - Patrik Edén
- Centre for Environmental and Climate Science, Lund University, Lund, Sweden
| | - Bertil Persson
- Department of Dermatology, Skåne University Hospital, Lund, Sweden
| | - Victor Olariu
- Centre for Environmental and Climate Science, Lund University, Lund, Sweden
| | - Malin Malmsjö
- Department of Clinical Sciences Lund, Ophthalmology, Lund University, Lund, Sweden
| | - Aboma Merdasa
- Department of Clinical Sciences Lund, Ophthalmology, Lund University, Lund, Sweden
| |
Collapse
|
16
|
Mashoudy KD, Perez SM, Nouri K. From diagnosis to intervention: a review of telemedicine's role in skin cancer care. Arch Dermatol Res 2024; 316:139. [PMID: 38696032 PMCID: PMC11065900 DOI: 10.1007/s00403-024-02884-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Revised: 04/03/2024] [Accepted: 04/14/2024] [Indexed: 05/05/2024]
Abstract
Skin cancer treatment is a core aspect of dermatology that relies on accurate diagnosis and timely interventions. Teledermatology has emerged as a valuable asset across various stages of skin cancer care including triage, diagnosis, management, and surgical consultation. With the integration of traditional dermoscopy and store-and-forward technology, teledermatology facilitates the swift sharing of high-resolution images of suspicious skin lesions with consulting dermatologists all-over. Both live video conference and store-and-forward formats have played a pivotal role in bridging the care access gap between geographically isolated patients and dermatology providers. Notably, teledermatology demonstrates diagnostic accuracy rates that are often comparable to those achieved through traditional face-to-face consultations, underscoring its robust clinical utility. Technological advancements like artificial intelligence and reflectance confocal microscopy continue to enhance image quality and hold potential for increasing the diagnostic accuracy of virtual dermatologic care. While teledermatology serves as a valuable clinical tool for all patient populations including pediatric patients, it is not intended to fully replace in-person procedures like Mohs surgery and other necessary interventions. Nevertheless, its role in facilitating the evaluation of skin malignancies is gaining recognition within the dermatologic community and fostering high approval rates from patients due to its practicality and ability to provide timely access to specialized care.
Collapse
Affiliation(s)
- Kayla D Mashoudy
- University of Miami Miller School of Medicine, 1600 NW 10th Ave #1140, Miami, FL, 33136, USA.
| | - Sofia M Perez
- University of Miami Miller School of Medicine, 1600 NW 10th Ave #1140, Miami, FL, 33136, USA
| | - Keyvan Nouri
- Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1150 NW 14th Street, Miami, FL, 33136, USA
| |
Collapse
|
17
|
Grzybowski A, Jin K, Wu H. Challenges of artificial intelligence in medicine and dermatology. Clin Dermatol 2024; 42:210-215. [PMID: 38184124 DOI: 10.1016/j.clindermatol.2023.12.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2024]
Abstract
Artificial intelligence (AI) in medicine and dermatology brings additional challenges related to bias, transparency, ethics, security, and inequality. Bias in AI algorithms can arise from biased training data or decision-making processes, leading to disparities in health care outcomes. Addressing bias requires careful examination of the data used to train AI models and implementation of strategies to mitigate bias during algorithm development. Transparency is another critical challenge, as AI systems often operate as black boxes, making it difficult to understand how decisions are reached. Ensuring transparency in AI algorithms is vital to gaining trust from both patients and health care providers. Ethical considerations arise when using AI in health care, including issues such as informed consent, privacy, and the responsibility for the decisions made by AI systems. It is essential to establish clear guidelines and frameworks that govern the ethical use of AI, including maintaining patient autonomy and protecting sensitive health information. Security is a significant concern in AI systems, as they rely on vast amounts of sensitive patient data. Protecting these data from unauthorized access, breaches, or malicious attacks is paramount to maintaining patient privacy and trust in AI technologies. Lastly, the potential for inequality arises if AI technologies are not accessible to all populations, leading to a digital divide in health care. Efforts should be made to ensure that AI solutions are affordable, accessible, and tailored to the needs of diverse communities, mitigating the risk of exacerbating existing health care disparities. Addressing these challenges is crucial for AI's responsible and equitable integration in medicine and dermatology.
Collapse
Affiliation(s)
- Andrzej Grzybowski
- Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland.
| | - Kai Jin
- Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - Hongkang Wu
- Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| |
Collapse
|
18
|
Primiero CA, Betz-Stablein B, Ascott N, D’Alessandro B, Gaborit S, Fricker P, Goldsteen A, González-Villà S, Lee K, Nazari S, Nguyen H, Ntouskos V, Pahde F, Pataki BE, Quintana J, Puig S, Rezze GG, Garcia R, Soyer HP, Malvehy J. A protocol for annotation of total body photography for machine learning to analyze skin phenotype and lesion classification. Front Med (Lausanne) 2024; 11:1380984. [PMID: 38654834 PMCID: PMC11035726 DOI: 10.3389/fmed.2024.1380984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Accepted: 03/25/2024] [Indexed: 04/26/2024] Open
Abstract
Introduction Artificial Intelligence (AI) has proven effective in classifying skin cancers using dermoscopy images. In experimental settings, algorithms have outperformed expert dermatologists in classifying melanoma and keratinocyte cancers. However, clinical application is limited when algorithms are presented with 'untrained' or out-of-distribution lesion categories, often misclassifying benign lesions as malignant, or misclassifying malignant lesions as benign. Another limitation often raised is the lack of clinical context (e.g., medical history) used as input for the AI decision process. The increasing use of Total Body Photography (TBP) in clinical examinations presents new opportunities for AI to perform holistic analysis of the whole patient, rather than a single lesion. Currently there is a lack of existing literature or standards for image annotation of TBP, or on preserving patient privacy during the machine learning process. Methods This protocol describes the methods for the acquisition of patient data, including TBP, medical history, and genetic risk factors, to create a comprehensive dataset for machine learning. 500 patients of various risk profiles will be recruited from two clinical sites (Australia and Spain), to undergo temporal total body imaging, complete surveys on sun behaviors and medical history, and provide a DNA sample. This patient-level metadata is applied to image datasets using DICOM labels. Anonymization and masking methods are applied to preserve patient privacy. A two-step annotation process is followed to label skin images for lesion detection and classification using deep learning models. Skin phenotype characteristics are extracted from images, including innate and facultative skin color, nevi distribution, and UV damage. Several algorithms will be developed relating to skin lesion detection, segmentation and classification, 3D mapping, change detection, and risk profiling. Simultaneously, explainable AI (XAI) methods will be incorporated to foster clinician and patient trust. Additionally, a publicly released dataset of anonymized annotated TBP images will be released for an international challenge to advance the development of new algorithms using this type of data. Conclusion The anticipated results from this protocol are validated AI-based tools to provide holistic risk assessment for individual lesions, and risk stratification of patients to assist clinicians in monitoring for skin cancer.
Collapse
Affiliation(s)
- Clare A. Primiero
- Dermatology Department, Hospital Clinic and Fundació Clínic per la Recerca Biomèdica—IDIBAPS, Barcelona, Spain
- Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia
| | - Brigid Betz-Stablein
- Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia
| | | | | | | | - Paul Fricker
- Torus Actions & Belle.ai, Ramonville-Saint-Agne, France
| | | | | | - Katie Lee
- Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia
| | - Sana Nazari
- Computer Vision and Robotics Group, University of Girona, Girona, Spain
| | - Hang Nguyen
- Torus Actions & Belle.ai, Ramonville-Saint-Agne, France
| | - Valsamis Ntouskos
- Remote Sensing Lab, National Technical University of Athens, Athens, Greece
| | | | - Balázs E. Pataki
- HUN-REN Institute for Computer Science and Control, Budapest, Hungary
| | | | - Susana Puig
- Dermatology Department, Hospital Clinic and Fundació Clínic per la Recerca Biomèdica—IDIBAPS, Barcelona, Spain
- Medicine Department, University of Barcelona, Barcelona, Spain
- CIBER de Enfermedades raras, Instituto de Salud Carlos III, Barcelona, Spain
| | - Gisele G. Rezze
- Dermatology Department, Hospital Clinic and Fundació Clínic per la Recerca Biomèdica—IDIBAPS, Barcelona, Spain
| | - Rafael Garcia
- Computer Vision and Robotics Group, University of Girona, Girona, Spain
| | - H. Peter Soyer
- Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia
- Dermatology Department, Princess Alexandra Hospital, Brisbane, QLD, Australia
| | - Josep Malvehy
- Dermatology Department, Hospital Clinic and Fundació Clínic per la Recerca Biomèdica—IDIBAPS, Barcelona, Spain
- Medicine Department, University of Barcelona, Barcelona, Spain
- CIBER de Enfermedades raras, Instituto de Salud Carlos III, Barcelona, Spain
| |
Collapse
|
19
|
Fliorent R, Fardman B, Podwojniak A, Javaid K, Tan IJ, Ghani H, Truong TM, Rao B, Heath C. Artificial intelligence in dermatology: advancements and challenges in skin of color. Int J Dermatol 2024; 63:455-461. [PMID: 38444331 DOI: 10.1111/ijd.17076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/13/2024] [Accepted: 01/30/2024] [Indexed: 03/07/2024]
Abstract
Artificial intelligence (AI) uses algorithms and large language models in computers to simulate human-like problem-solving and decision-making. AI programs have recently acquired widespread popularity in the field of dermatology through the application of online tools in the assessment, diagnosis, and treatment of skin conditions. A literature review was conducted using PubMed and Google Scholar analyzing recent literature (from the last 10 years through October 2023) to evaluate current AI programs in use for dermatologic purposes, identifying challenges in this technology when applied to skin of color (SOC), and proposing future steps to enhance the role of AI in dermatologic practice. Challenges surrounding AI and its application to SOC stem from the underrepresentation of SOC in datasets and issues with image quality and standardization. With these existing issues, current AI programs inevitably do worse at identifying lesions in SOC. Additionally, only 30% of the programs identified in this review had data reported on their use in dermatology, specifically in SOC. Significant development of these applications is required for the accurate depiction of darker skin tone images in datasets. More research is warranted in the future to better understand the efficacy of AI in aiding diagnosis and treatment options for SOC patients.
Collapse
Affiliation(s)
| | - Brian Fardman
- Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ, USA
| | | | - Kiran Javaid
- Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ, USA
| | - Isabella J Tan
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - Hira Ghani
- Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Thu M Truong
- Center for Dermatology, Rutgers Robert Wood Johnson, Somerset, NJ, USA
| | - Babar Rao
- Center for Dermatology, Rutgers Robert Wood Johnson, Somerset, NJ, USA
| | - Candrice Heath
- Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
| |
Collapse
|
20
|
Maleki Varnosfaderani S, Forouzanfar M. The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century. Bioengineering (Basel) 2024; 11:337. [PMID: 38671759 PMCID: PMC11047988 DOI: 10.3390/bioengineering11040337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Revised: 03/25/2024] [Accepted: 03/26/2024] [Indexed: 04/28/2024] Open
Abstract
As healthcare systems around the world face challenges such as escalating costs, limited access, and growing demand for personalized care, artificial intelligence (AI) is emerging as a key force for transformation. This review is motivated by the urgent need to harness AI's potential to mitigate these issues and aims to critically assess AI's integration in different healthcare domains. We explore how AI empowers clinical decision-making, optimizes hospital operation and management, refines medical image analysis, and revolutionizes patient care and monitoring through AI-powered wearables. Through several case studies, we review how AI has transformed specific healthcare domains and discuss the remaining challenges and possible solutions. Additionally, we will discuss methodologies for assessing AI healthcare solutions, ethical challenges of AI deployment, and the importance of data privacy and bias mitigation for responsible technology use. By presenting a critical assessment of AI's transformative potential, this review equips researchers with a deeper understanding of AI's current and future impact on healthcare. It encourages an interdisciplinary dialogue between researchers, clinicians, and technologists to navigate the complexities of AI implementation, fostering the development of AI-driven solutions that prioritize ethical standards, equity, and a patient-centered approach.
Collapse
Affiliation(s)
| | - Mohamad Forouzanfar
- Département de Génie des Systèmes, École de Technologie Supérieure (ÉTS), Université du Québec, Montréal, QC H3C 1K3, Canada
- Centre de Recherche de L’institut Universitaire de Gériatrie de Montréal (CRIUGM), Montréal, QC H3W 1W5, Canada
| |
Collapse
|
21
|
Karadag AS, Kandi B, Sanlı B, Ulusal H, Basusta H, Sener S, Calıka S. Social Media Use in Dermatology in Turkey: Challenges and Tips for Patient Health. JMIR DERMATOLOGY 2024; 7:e51267. [PMID: 38546714 PMCID: PMC11009853 DOI: 10.2196/51267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 01/25/2024] [Accepted: 01/28/2024] [Indexed: 04/14/2024] Open
Abstract
Social media has established its place in our daily lives, especially with the advent of the COVID-19 pandemic. It has become the leading source of information for dermatological literacy on various topics, ranging from skin diseases to everyday skincare and cosmetic purposes in the present digital era. Accumulated evidence indicates that accurate medical content constitutes only a tiny fraction of the exponentially growing dermatological information on digital platforms, highlighting an unmet patient need for access to evidence-based information on social media. However, there have been no recent local publications from Turkey analyzing and assessing the key elements in raising dermatological literacy and awareness in digital communication for patients. To the best of our knowledge, this study is the first collaborative work between health care professionals and a social media specialist in the medical literature. Furthermore, it represents the first author-initiated implementation science attempt focusing on the use of social media in addressing dermatological problems, with the primary end point of increasing health literacy and patient benefits. The multidisciplinary expert panel was formed by 4 dermatologists with academic credentials and significant influence in public health and among patients on digital platforms. A social media specialist, who serves as a guest lecturer on "How social media works" at Istanbul Technical University, Turkey, was invited to the panel as an expert on digital communication. The panel members had a kickoff meeting to establish the context for the discussion points. The context of the advisory board meeting was outlined under 5 headlines. Two weeks later, the panel members presented their social media account statistics, defined the main characteristics of dermatology patients on social media, and discussed their experiences with patients on digital platforms. These discussions were organized under the predefined headlines and in line with the current literature. We aimed to collect expert opinions on identifying the main characteristics of individuals interested in dermatological topics and to provide recommendations to help dermatologists increase evidence-based dermatological content on social media. Additionally, experts discussed paradigms for dermatological outreach and the role of dermatologists in reducing misleading information on digital platforms in Turkey. The main concluding remark of this study is that dermatologists should enhance their social media presence to increase evidence-based knowledge by applying the principles of patient-physician communication on digital platforms while maintaining a professional stance. To achieve this goal, dermatologists should share targeted scientific content after increasing their knowledge about the operational rules of digital channels. This includes correctly identifying the needs of those seeking information on social media and preparing a sustainable social media communication plan. This viewpoint reflects Turkish dermatologists' experiences with individuals searching for dermatological information on local digital platforms; therefore, the applicability of recommendations may be limited and should be carefully considered.
Collapse
Affiliation(s)
- Ayse Serap Karadag
- Department of Dermatology, Medical School of Istanbul Arel University, Istanbul, Turkey
| | | | - Berna Sanlı
- Department of Dermatology, Medical School of Pamukkale University, Denizli, Turkey
| | - Hande Ulusal
- Department of Dermatology, Medical School of Biruni University, Istanbul, Turkey
| | | | | | | |
Collapse
|
22
|
Kaliyadan F, Chatterjee K. 'Big-Data' in dermatological research. Indian J Dermatol Venereol Leprol 2024; 0:1-3. [PMID: 38594987 DOI: 10.25259/ijdvl_1298_2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Accepted: 01/05/2024] [Indexed: 04/11/2024]
Affiliation(s)
- Feroze Kaliyadan
- Department of Dermatology, Sree Narayana Institute of Medical Sciences, Kochi, Kerala, India
| | - Kingshuk Chatterjee
- Department of Dermatology, Nil Ratan Sircar (NRS) Medical College Kolkata, Burdwan, India
| |
Collapse
|
23
|
Tommasino N, Megna M, Cacciapuoti S, Villani A, Martora F, Ruggiero A, Genco L, Potestio L. The Past, the Present and the Future of Teledermatology: A Narrative Review. Clin Cosmet Investig Dermatol 2024; 17:717-723. [PMID: 38529172 PMCID: PMC10962464 DOI: 10.2147/ccid.s462799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2024] [Accepted: 03/17/2024] [Indexed: 03/27/2024]
Abstract
Teledermatology may be defined as the application of telemedicine to dermatology. According to published data, teledermatology is more widespread in Europe and North America, probably where resources for health care are greater than in other areas of the world. Indeed, teledermatology requires advanced technology to be efficient, as high image quality is necessary to allow the dermatologist to make correct diagnoses. Thanks to the recent advances in this field, teledermatology is become routinary in daily clinical practice. However, its use has been improved over time, overcoming several challenges. The aim of this narrative review is to retrace the almost 30-year history of teledermatology, to address the new challenges posed by advancing technologies such as artificial intelligence and the implications it may have on healthcare.
Collapse
Affiliation(s)
- Nello Tommasino
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Matteo Megna
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Sara Cacciapuoti
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Alessia Villani
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Fabrizio Martora
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Angelo Ruggiero
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Lucia Genco
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Luca Potestio
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| |
Collapse
|
24
|
Rey R, Gualtieri R, La Scala G, Posfay Barbe K. Artificial Intelligence in the Diagnosis and Management of Appendicitis in Pediatric Departments: A Systematic Review. Eur J Pediatr Surg 2024. [PMID: 38290564 DOI: 10.1055/a-2257-5122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2024]
Abstract
INTRODUCTION Artificial intelligence (AI) is a growing field in medical research that could potentially help in the challenging diagnosis of acute appendicitis (AA) in children. However, usefulness of AI in clinical settings remains unclear. Our aim was to assess the accuracy of AIs in the diagnosis of AA in the pediatric population through a systematic literature review. METHODS PubMed, Embase, and Web of Science were searched using the following keywords: "pediatric," "artificial intelligence," "standard practices," and "appendicitis," up to September 2023. The risk of bias was assessed using PROBAST. RESULTS A total of 302 articles were identified and nine articles were included in the final review. Two studies had prospective validation, seven were retrospective, and no randomized control trials were found. All studies developed their own algorithms and had an accuracy greater than 90% or area under the curve >0.9. All studies were rated as a "high risk" concerning their overall risk of bias. CONCLUSION We analyzed the current status of AI in the diagnosis of appendicitis in children. The application of AI shows promising potential, but the need for more rigor in study design, reporting, and transparency is urgent to facilitate its clinical implementation.
Collapse
Affiliation(s)
- Robin Rey
- Department of Human Medicine, Faculty of Medicine, University of Geneva, Genève, Switzerland
| | - Renato Gualtieri
- Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Genève, Switzerland
| | - Giorgio La Scala
- Division of Pediatric Surgery, Hôpital des enfants, Geneva University Hospitals, Genève, Switzerland
| | - Klara Posfay Barbe
- Division of General Pediatrics, Hôpital des enfants, Geneva University Hospitals, Genève, Switzerland
| |
Collapse
|
25
|
Goessinger EV, Niederfeilner JC, Cerminara S, Maul JT, Kostner L, Kunz M, Huber S, Koral E, Habermacher L, Sabato G, Tadic A, Zimmermann C, Navarini A, Maul LV. Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study. J Eur Acad Dermatol Venereol 2024. [PMID: 38411348 DOI: 10.1111/jdv.19905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2023] [Accepted: 01/22/2024] [Indexed: 02/28/2024]
Abstract
BACKGROUND Artificial intelligence (AI) shows promising potential to enhance human decision-making as synergistic augmented intelligence (AuI), but requires critical evaluation for skin cancer screening in a real-world setting. OBJECTIVES To investigate the perspectives of patients and dermatologists after skin cancer screening by human, artificial and augmented intelligence. METHODS A prospective comparative cohort study conducted at the University Hospital Basel included 205 patients (at high-risk of developing melanoma, with resected or advanced disease) and 8 dermatologists. Patients underwent skin cancer screening by a dermatologist with subsequent 2D and 3D total-body photography (TBP). Any suspicious and all melanocytic skin lesions ≥3 mm were imaged with digital dermoscopes and classified by corresponding convolutional neural networks (CNNs). Excisions were performed based on dermatologist's melanoma suspicion, study-defined elevated CNN risk-scores and/or melanoma suspicion by AuI. Subsequently, all patients and dermatologists were surveyed about their experience using questionnaires, including quantification of patient's safety sense following different examinations (subjective safety score (SSS): 0-10). RESULTS Most patients believed AI could improve diagnostic performance (95.5%, n = 192/201). In total, 83.4% preferred AuI-based skin cancer screening compared to examination by AI or dermatologist alone (3D-TBP: 61.3%; 2D-TBP: 22.1%, n = 199). Regarding SSS, AuI induced a significantly higher feeling of safety than AI (mean-SSS (mSSS): 9.5 vs. 7.7, p < 0.0001) or dermatologist screening alone (mSSS: 9.5 vs. 9.1, p = 0.001). Most dermatologists expressed high trust in AI examination results (3D-TBP: 90.2%; 2D-TBP: 96.1%, n = 205). In 68.3% of the examinations, dermatologists felt that diagnostic accuracy improved through additional AI-assessment (n = 140/205). Especially beginners (<2 years' dermoscopic experience; 61.8%, n = 94/152) felt AI facilitated their clinical work compared to experts (>5 years' dermoscopic experience; 20.9%, n = 9/43). Contrarily, in divergent risk assessments, only 1.5% of dermatologists trusted a benign CNN-classification more than personal malignancy suspicion (n = 3/205). CONCLUSIONS While patients already prefer AuI with 3D-TBP for melanoma recognition, dermatologists continue to rely largely on their own decision-making despite high confidence in AI-results. TRIAL REGISTRATION ClinicalTrials.gov (NCT04605822).
Collapse
Affiliation(s)
- Elisabeth Victoria Goessinger
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | | | - Sara Cerminara
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | - Julia-Tatjana Maul
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- Faculty of Medicine, University of Zurich, Zurich, Switzerland
| | - Lisa Kostner
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | - Michael Kunz
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | - Stephanie Huber
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - Emrah Koral
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - Lea Habermacher
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | - Gianna Sabato
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | - Andrea Tadic
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | | | - Alexander Navarini
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
- Faculty of Medicine, University of Basel, Basel, Switzerland
| | - Lara Valeska Maul
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
- Faculty of Medicine, University of Basel, Basel, Switzerland
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- Faculty of Medicine, University of Zurich, Zurich, Switzerland
| |
Collapse
|
26
|
Shah A, Wahood S, Guermazi D, Brem CE, Saliba E. Skin and Syntax: Large Language Models in Dermatopathology. Dermatopathology (Basel) 2024; 11:101-111. [PMID: 38390851 PMCID: PMC10885095 DOI: 10.3390/dermatopathology11010009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2024] [Revised: 02/04/2024] [Accepted: 02/08/2024] [Indexed: 02/24/2024] Open
Abstract
This literature review introduces the integration of Large Language Models (LLMs) in the field of dermatopathology, outlining their potential benefits, challenges, and prospects. It discusses the changing landscape of dermatopathology with the emergence of LLMs. The potential advantages of LLMs include a streamlined generation of pathology reports, the ability to learn and provide up-to-date information, and simplified patient education. Existing instances of LLMs encompass diagnostic support, research acceleration, and trainee education. Challenges involve biases, data privacy and quality, and establishing a balance between AI and dermatopathological expertise. Prospects include the integration of LLMs with other AI technologies to improve diagnostics and the improvement of multimodal LLMs that can handle both text and image input. Our implementation guidelines highlight the importance of model transparency and interpretability, data quality, and continuous oversight. The transformative potential of LLMs in dermatopathology is underscored, with an emphasis on a dynamic collaboration between artificial intelligence (AI) experts (technical specialists) and dermatopathologists (clinicians) for improved patient outcomes.
Collapse
Affiliation(s)
- Asghar Shah
- Department of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA
| | - Samer Wahood
- Department of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA
| | - Dorra Guermazi
- Department of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA
| | - Candice E Brem
- Section of Dermatopathology, Department of Dermatology, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA 02118, USA
| | - Elie Saliba
- Department of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA
- Department of Dermatology, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut 13-5053, Lebanon
| |
Collapse
|
27
|
Singh P, Bornstein MM, Hsung RTC, Ajmera DH, Leung YY, Gu M. Frontiers in Three-Dimensional Surface Imaging Systems for 3D Face Acquisition in Craniofacial Research and Practice: An Updated Literature Review. Diagnostics (Basel) 2024; 14:423. [PMID: 38396462 PMCID: PMC10888365 DOI: 10.3390/diagnostics14040423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Revised: 02/02/2024] [Accepted: 02/08/2024] [Indexed: 02/25/2024] Open
Abstract
Digitalizing all aspects of dental care is a contemporary approach to ensuring the best possible clinical outcomes. Ongoing advancements in 3D face acquisition have been driven by continuous research on craniofacial structures and treatment effects. An array of 3D surface-imaging systems are currently available for generating photorealistic 3D facial images. However, choosing a purpose-specific system is challenging for clinicians due to variations in accuracy, reliability, resolution, and portability. Therefore, this review aims to provide clinicians and researchers with an overview of currently used or potential 3D surface imaging technologies and systems for 3D face acquisition in craniofacial research and daily practice. Through a comprehensive literature search, 71 articles meeting the inclusion criteria were included in the qualitative analysis, investigating the hardware, software, and operational aspects of these systems. The review offers updated information on 3D surface imaging technologies and systems to guide clinicians in selecting an optimal 3D face acquisition system. While some of these systems have already been implemented in clinical settings, others hold promise. Furthermore, driven by technological advances, novel devices will become cost-effective and portable, and will also enable accurate quantitative assessments, rapid treatment simulations, and improved outcomes.
Collapse
Affiliation(s)
- Pradeep Singh
- Discipline of Orthodontics, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China; (P.S.); (D.H.A.)
| | - Michael M. Bornstein
- Department of Oral Health & Medicine, University Center for Dental Medicine Basel UZB, University of Basel, Mattenstrasse 40, 4058 Basel, Switzerland;
| | - Richard Tai-Chiu Hsung
- Department of Computer Science, Hong Kong Chu Hai College, Hong Kong SAR, China;
- Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China;
| | - Deepal Haresh Ajmera
- Discipline of Orthodontics, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China; (P.S.); (D.H.A.)
| | - Yiu Yan Leung
- Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China;
| | - Min Gu
- Discipline of Orthodontics, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China; (P.S.); (D.H.A.)
| |
Collapse
|
28
|
Jagemann I, Wensing O, Stegemann M, Hirschfeld G. Acceptance of Medical Artificial Intelligence in Skin Cancer Screening: Choice-Based Conjoint Survey. JMIR Form Res 2024; 8:e46402. [PMID: 38214959 PMCID: PMC10818228 DOI: 10.2196/46402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 08/17/2023] [Accepted: 11/20/2023] [Indexed: 01/13/2024] Open
Abstract
BACKGROUND There is great interest in using artificial intelligence (AI) to screen for skin cancer. This is fueled by a rising incidence of skin cancer and an increasing scarcity of trained dermatologists. AI systems capable of identifying melanoma could save lives, enable immediate access to screenings, and reduce unnecessary care and health care costs. While such AI-based systems are useful from a public health perspective, past research has shown that individual patients are very hesitant about being examined by an AI system. OBJECTIVE The aim of this study was two-fold: (1) to determine the relative importance of the provider (in-person physician, physician via teledermatology, AI, personalized AI), costs of screening (free, 10€, 25€, 40€; 1€=US $1.09), and waiting time (immediate, 1 day, 1 week, 4 weeks) as attributes contributing to patients' choices of a particular mode of skin cancer screening; and (2) to investigate whether sociodemographic characteristics, especially age, were systematically related to participants' individual choices. METHODS A choice-based conjoint analysis was used to examine the acceptance of medical AI for a skin cancer screening from the patient's perspective. Participants responded to 12 choice sets, each containing three screening variants, where each variant was described through the attributes of provider, costs, and waiting time. Furthermore, the impacts of sociodemographic characteristics (age, gender, income, job status, and educational background) on the choices were assessed. RESULTS Among the 383 clicks on the survey link, a total of 126 (32.9%) respondents completed the online survey. The conjoint analysis showed that the three attributes had more or less equal importance in contributing to the participants' choices, with provider being the most important attribute. Inspecting the individual part-worths of conjoint attributes showed that treatment by a physician was the most preferred modality, followed by electronic consultation with a physician and personalized AI; the lowest scores were found for the three AI levels. Concerning the relationship between sociodemographic characteristics and relative importance, only age showed a significant positive association to the importance of the attribute provider (r=0.21, P=.02), in which younger participants put less importance on the provider than older participants. All other correlations were not significant. CONCLUSIONS This study adds to the growing body of research using choice-based experiments to investigate the acceptance of AI in health contexts. Future studies are needed to explore the reasons why AI is accepted or rejected and whether sociodemographic characteristics are associated with this decision.
Collapse
Affiliation(s)
- Inga Jagemann
- School of Business, University of Applied Sciences and Arts Bielefeld, Bielefeld, Germany
| | - Ole Wensing
- School of Business, University of Applied Sciences and Arts Bielefeld, Bielefeld, Germany
| | - Manuel Stegemann
- School of Business, University of Applied Sciences and Arts Bielefeld, Bielefeld, Germany
| | - Gerrit Hirschfeld
- School of Business, University of Applied Sciences and Arts Bielefeld, Bielefeld, Germany
| |
Collapse
|
29
|
Kawsar A, Hussain K, Kalsi D, Kemos P, Marsden H, Thomas L. Patient perspectives of artificial intelligence as a medical device in a skin cancer pathway. Front Med (Lausanne) 2023; 10:1259595. [PMID: 38046409 PMCID: PMC10693417 DOI: 10.3389/fmed.2023.1259595] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Accepted: 10/27/2023] [Indexed: 12/05/2023] Open
Abstract
The use of artificial intelligence as a medical device (AIaMD) in healthcare systems is increasing rapidly. In dermatology, this has been accelerated in response to increasing skin cancer referral rates, workforce shortages and backlog generated by the COVID-19 pandemic. Evidence regarding patient perspectives of AIaMD is currently lacking in the literature. Patient acceptability is fundamental if this novel technology is to be effectively integrated into care pathways and patients must be confident that it is implemented safely, legally, and ethically. A prospective, single-center, single-arm, masked, non-inferiority, adaptive, group sequential design trial, recruited patients referred to a teledermatology cancer pathway. AIaMD assessment of dermoscopic images were compared with clinical or histological diagnosis, to assess performance (NCT04123678). Participants completed an online questionnaire to evaluate their views regarding use of AIaMD in the skin cancer pathway. Two hundred and sixty eight responses were received between February 2020 and August 2021. The majority of respondents were female (57.5%), ranged in age between 18 and 93 years old, Fitzpatrick type I-II skin (81.3%) and all 6 skin types were represented. Overall, there was a positive sentiment regarding potential use of AIaMD in skin cancer pathways. The majority of respondents felt confident in computers being used to help doctors diagnose and formulate management plans (median = 70; interquartile range (IQR) = 50-95) and as a support tool for general practitioners when assessing skin lesions (median = 85; IQR = 65-100). Respondents were comfortable having their photographs taken with a mobile phone device (median = 95; IQR = 70-100), which is similar to other studies assessing patient acceptability of teledermatology services. To the best of our knowledge, this is the first comprehensive study evaluating patient perspectives of AIaMD in skin cancer pathways in the UK. Patient involvement is essential for the development and implementation of new technologies. Continued end-user feedback will allow refinement of services to ensure patient acceptability. This study demonstrates patient acceptability of the use of AIaMD in both primary and secondary care settings.
Collapse
Affiliation(s)
- Anusuya Kawsar
- Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
| | - Khawar Hussain
- Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
| | | | - Polychronis Kemos
- Skin Analytics Ltd., London, United Kingdom
- Blizard Institute, Queen Mary University of London, London, United Kingdom
| | | | - Lucy Thomas
- Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
| |
Collapse
|
30
|
Wang G, Meng X, Zhang F. Past, present, and future of global research on artificial intelligence applications in dermatology: A bibliometric analysis. Medicine (Baltimore) 2023; 102:e35993. [PMID: 37960748 PMCID: PMC10637496 DOI: 10.1097/md.0000000000035993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Accepted: 10/17/2023] [Indexed: 11/15/2023] Open
Abstract
In recent decades, artificial intelligence (AI) has played an increasingly important role in medicine, including dermatology. Worldwide, numerous studies have reported on AI applications in dermatology, rapidly increasing interest in this field. However, no bibliometric studies have been conducted to evaluate the past, present, or future of this topic. This study aimed to illustrate past and present research and outline future directions for global research on AI applications in dermatology using bibliometric analysis. We conducted an online search of the Web of Science Core Collection database to identify scientific papers on AI applications in dermatology. The bibliometric metadata of each selected paper were extracted, analyzed, and visualized using VOS viewer and Cite Space. A total of 406 papers, comprising 8 randomized controlled trials and 20 prospective studies, were deemed eligible for inclusion. The United States had the highest number of papers (n = 166). The University of California System (n = 24) and Allan C. Halpern (n = 11) were the institution and author with the highest number of papers, respectively. Based on keyword co-occurrence analysis, the studies were categorized into 9 distinct clusters, with clusters 2, 3, and 7 containing keywords with the latest average publication year. Wound progression prediction using machine learning, the integration of AI into teledermatology, and applications of the algorithms in skin diseases, are the current research priorities and will remain future research aims in this field.
Collapse
Affiliation(s)
- Guangxin Wang
- Shandong Innovation Center of Intelligent Diagnosis, Jinan Central Hospital, Shandong University, Jinan, Shandong, China
| | - Xianguang Meng
- Department of Dermatology, Jinan Central Hospital, Shandong University, Jinan, Shandong, China
| | - Fan Zhang
- Shandong Innovation Center of Intelligent Diagnosis, Jinan Central Hospital, Shandong University, Jinan, Shandong, China
| |
Collapse
|
31
|
Sengupta D. Artificial Intelligence in Diagnostic Dermatology: Challenges and the Way Forward. Indian Dermatol Online J 2023; 14:782-787. [PMID: 38099026 PMCID: PMC10718130 DOI: 10.4103/idoj.idoj_462_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 08/07/2023] [Accepted: 08/17/2023] [Indexed: 12/17/2023] Open
Abstract
Artificial Intelligence (AI) has emerged as a transformative force in the field of diagnostic dermatology, offering unprecedented capabilities in image recognition and data analysis. Despite its promise, the integration of AI into clinical practice faces multifaceted challenges that span technical, ethical, and regulatory domains. This article provides a narrative overview of the current state of AI in dermatology, tracing its historical evolution from early diagnostic tools to contemporary hybrid supervised models. We identify and categorize six critical challenges: data quality and quantity, algorithmic development and explainability, ethical considerations, clinical workflow integration, regulatory frameworks, and stakeholder collaboration. Each challenge is dissected from the perspectives of academia, industry, and healthcare providers, offering actionable recommendations for future research and implementation. We also highlight the paradigm shift in AI research, emphasizing the potential of transformer architectures in revolutionizing diagnostic methodologies. By addressing the challenges and harnessing the latest advancements, AI has the potential to significantly impact diagnostic accuracy and patient outcomes in dermatology.
Collapse
Affiliation(s)
- Dipayan Sengupta
- Consultant Dermatologist, Euro Skin Cliniq, Kolkata, West Bengal, India
| |
Collapse
|
32
|
Ly S, Reyes-Hadsall S, Drake L, Zhou G, Nelson C, Barbieri JS, Mostaghimi A. Public Perceptions, Factors, and Incentives Influencing Patient Willingness to Share Clinical Images for Artificial Intelligence-Based Healthcare Tools. Dermatol Ther (Heidelb) 2023; 13:2895-2902. [PMID: 37737327 PMCID: PMC10613161 DOI: 10.1007/s13555-023-01031-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Accepted: 09/07/2023] [Indexed: 09/23/2023] Open
Abstract
INTRODUCTION The use of artificial intelligence (AI) as a diagnostic and decision-support tool is increasing in dermatology. The accuracy of image-based AI tools is incumbent on images in training sets, which requires patient consent for sharing. This study aims to understand individuals' willingness to share their images for AI and variables that influence willingness. METHODS In an online survey administered via Amazon Mechanical Turk, sketches of the hand, face, and genitalia assigned to two use cases employing AI (research vs. personal medical care) were shown. Participants rated willingness to share the image on a 7-point Likert scale. RESULTS Of the 1010 participants, individuals were most willing to share images of their hands (81.2%), face (70.3%), and lastly genitals (male: 56.8%, female: 46.7%). Individuals were more willing to share for personal care versus research (OR 0.77 [95% CI 0.69-0.86]). Willingness to share was higher among males, participants with higher education, tech-savvy participants, and frequent social media users. Most participants were willing to share images if offered monetary compensation, with face images requiring the highest payment (mean $18.25, SD 20.05). Only 38.7% of individuals refused image sharing regardless of any monetary compensation, with the majority of this group unwilling to share images of the genitals. CONCLUSIONS This study demonstrates overall public support for sharing images to AI-based tools in dermatology, with influencing factors including image type, context, education level, technology comfort, social media use, and monetary compensation.
Collapse
Affiliation(s)
- Sophia Ly
- College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA
| | - Sophia Reyes-Hadsall
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA
- Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Lara Drake
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA
- School of Medicine, Tufts University, Boston, MA, USA
| | - Guohai Zhou
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA
| | - Caroline Nelson
- Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
| | - John S Barbieri
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA
- Department of Dermatology, Harvard Medical School, Boston, MA, USA
| | - Arash Mostaghimi
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
- Department of Dermatology, Harvard Medical School, Boston, MA, USA.
| |
Collapse
|
33
|
Debelee TG. Skin Lesion Classification and Detection Using Machine Learning Techniques: A Systematic Review. Diagnostics (Basel) 2023; 13:3147. [PMID: 37835889 PMCID: PMC10572538 DOI: 10.3390/diagnostics13193147] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 09/22/2023] [Accepted: 09/24/2023] [Indexed: 10/15/2023] Open
Abstract
Skin lesions are essential for the early detection and management of a number of dermatological disorders. Learning-based methods for skin lesion analysis have drawn much attention lately because of improvements in computer vision and machine learning techniques. A review of the most-recent methods for skin lesion classification, segmentation, and detection is presented in this survey paper. The significance of skin lesion analysis in healthcare and the difficulties of physical inspection are discussed in this survey paper. The review of state-of-the-art papers targeting skin lesion classification is then covered in depth with the goal of correctly identifying the type of skin lesion from dermoscopic, macroscopic, and other lesion image formats. The contribution and limitations of various techniques used in the selected study papers, including deep learning architectures and conventional machine learning methods, are examined. The survey then looks into study papers focused on skin lesion segmentation and detection techniques that aimed to identify the precise borders of skin lesions and classify them accordingly. These techniques make it easier to conduct subsequent analyses and allow for precise measurements and quantitative evaluations. The survey paper discusses well-known segmentation algorithms, including deep-learning-based, graph-based, and region-based ones. The difficulties, datasets, and evaluation metrics particular to skin lesion segmentation are also discussed. Throughout the survey, notable datasets, benchmark challenges, and evaluation metrics relevant to skin lesion analysis are highlighted, providing a comprehensive overview of the field. The paper concludes with a summary of the major trends, challenges, and potential future directions in skin lesion classification, segmentation, and detection, aiming to inspire further advancements in this critical domain of dermatological research.
Collapse
Affiliation(s)
- Taye Girma Debelee
- Ethiopian Artificial Intelligence Institute, Addis Ababa 40782, Ethiopia;
- Department of Electrical and Computer Engineering, Addis Ababa Science and Technology University, Addis Ababa 16417, Ethiopia
| |
Collapse
|
34
|
Mancha D, Filipe P. Phototherapy in the artificial intelligence era. PHOTODERMATOLOGY, PHOTOIMMUNOLOGY & PHOTOMEDICINE 2023; 39:538-539. [PMID: 37259232 DOI: 10.1111/phpp.12890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Revised: 05/09/2023] [Accepted: 05/23/2023] [Indexed: 06/02/2023]
Affiliation(s)
- D Mancha
- Dermatology Department, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal
| | - P Filipe
- Dermatology Department, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal
- Dermatology University Clinic, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
- Dermatology Research Unit (PFilipe Lab), Instituto de Medicina Molecular João Lobo Antunes, University of Lisbon, Lisbon, Portugal
| |
Collapse
|
35
|
Nervil GG, Ternov NK, Vestergaard T, Sølvsten H, Chakera AH, Tolsgaard MG, Hölmich LR. Improving Skin Cancer Diagnostics Through a Mobile App With a Large Interactive Image Repository: Randomized Controlled Trial. JMIR DERMATOLOGY 2023; 6:e48357. [PMID: 37624707 PMCID: PMC10448292 DOI: 10.2196/48357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Accepted: 07/03/2023] [Indexed: 08/27/2023] Open
Abstract
BACKGROUND Skin cancer diagnostics is challenging, and mastery requires extended periods of dedicated practice. OBJECTIVE The aim of the study was to determine if self-paced pattern recognition training in skin cancer diagnostics with clinical and dermoscopic images of skin lesions using a large-scale interactive image repository (LIIR) with patient cases improves primary care physicians' (PCPs') diagnostic skills and confidence. METHODS A total of 115 PCPs were randomized (allocation ratio 3:1) to receive or not receive self-paced pattern recognition training in skin cancer diagnostics using an LIIR with patient cases through a quiz-based smartphone app during an 8-day period. The participants' ability to diagnose skin cancer was evaluated using a 12-item multiple-choice questionnaire prior to and 8 days after the educational intervention period. Their thoughts on the use of dermoscopy were assessed using a study-specific questionnaire. A learning curve was calculated through the analysis of data from the mobile app. RESULTS On average, participants in the intervention group spent 2 hours 26 minutes quizzing digital patient cases and 41 minutes reading the educational material. They had an average preintervention multiple choice questionnaire score of 52.0% of correct answers, which increased to 66.4% on the postintervention test; a statistically significant improvement of 14.3 percentage points (P<.001; 95% CI 9.8-18.9) with intention-to-treat analysis. Analysis of participants who received the intervention as per protocol (500 patient cases in 8 days) showed an average increase of 16.7 percentage points (P<.001; 95% CI 11.3-22.0) from 53.9% to 70.5%. Their overall ability to correctly recognize malignant lesions in the LIIR patient cases improved over the intervention period by 6.6 percentage points from 67.1% (95% CI 65.2-69.3) to 73.7% (95% CI 72.5-75.0) and their ability to set the correct diagnosis improved by 10.5 percentage points from 42.5% (95% CI 40.2%-44.8%) to 53.0% (95% CI 51.3-54.9). The diagnostic confidence of participants in the intervention group increased on a scale from 1 to 4 by 32.9% from 1.6 to 2.1 (P<.001). Participants in the control group did not increase their postintervention score or their diagnostic confidence during the same period. CONCLUSIONS Self-paced pattern recognition training in skin cancer diagnostics through the use of a digital LIIR with patient cases delivered by a quiz-based mobile app improves the diagnostic accuracy of PCPs. TRIAL REGISTRATION ClinicalTrials.gov NCT05661370; https://classic.clinicaltrials.gov/ct2/show/NCT05661370.
Collapse
Affiliation(s)
- Gustav Gede Nervil
- Department of Plastic Surgery, Herlev-Gentofte Hospital, Herlev, Denmark
| | | | - Tine Vestergaard
- Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark
| | | | | | - Martin Grønnebæk Tolsgaard
- Copenhagen Academy for Medical Education and Simulation, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
- Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
| | - Lisbet Rosenkrantz Hölmich
- Department of Plastic Surgery, Herlev-Gentofte Hospital, Herlev, Denmark
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
36
|
Giansanti D. Advancing Dermatological Care: A Comprehensive Narrative Review of Tele-Dermatology and mHealth for Bridging Gaps and Expanding Opportunities beyond the COVID-19 Pandemic. Healthcare (Basel) 2023; 11:1911. [PMID: 37444745 DOI: 10.3390/healthcare11131911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 06/20/2023] [Accepted: 06/21/2023] [Indexed: 07/15/2023] Open
Abstract
Mobile health (mHealth) has recently had significant advances in tele-dermatology (TD) thanks to the developments following the COVID-19 pandemic. This topic is very important, as telemedicine and mHealth, when applied to dermatology, could improve both the quality of healthcare for citizens and the workflow in the health domain. The proposed study was centered on the last three years. We conducted an overview on the opportunities, the perspectives, and the problems involved in TD integration with mHealth. The methodology of the narrative review was based on: (I) a search of PubMed and Scopus and (II) an eligibility assessment, using properly proposed parameters. The outcome of the study showed that during the COVID-19 pandemic, TD integration with mHealth advanced rapidly. This integration enabled the monitoring of dermatological problems and facilitated remote specialist visits, reducing face-to-face interactions. AI and mobile apps have empowered citizens to take an active role in their healthcare. This differs from other imaging sectors where information exchange is limited to professionals. The opportunities for TD in mHealth include improving service quality, streamlining healthcare processes, reducing costs, and providing more accessible care. It can be applied to various conditions, such as (but not limited to) acne, vitiligo, psoriasis, and skin cancers. Integration with AI and augmented reality (AR), as well as the use of wearable sensors, are anticipated as future developments. However, integrating TD with mHealth also brings about problems and challenges related to regulations, ethics, cybersecurity, data privacy, and device management. Scholars and policymakers need to address these issues while involving citizens in the process.
Collapse
|
37
|
Giansanti D. The Artificial Intelligence in Teledermatology: A Narrative Review on Opportunities, Perspectives, and Bottlenecks. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:ijerph20105810. [PMID: 37239537 DOI: 10.3390/ijerph20105810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/16/2023] [Revised: 04/27/2023] [Accepted: 05/03/2023] [Indexed: 05/28/2023]
Abstract
Artificial intelligence (AI) is recently seeing significant advances in teledermatology (TD), also thanks to the developments that have taken place during the COVID-19 pandemic. In the last two years, there was an important development of studies that focused on opportunities, perspectives, and problems in this field. The topic is very important because the telemedicine and AI applied to dermatology have the opportunity to improve both the quality of healthcare for citizens and the workflow of healthcare professionals. This study conducted an overview on the opportunities, the perspectives, and the problems related to the integration of TD with AI. The methodology of this review, following a standardized checklist, was based on: (I) a search of PubMed and Scopus and (II) an eligibility assessment, using parameters with five levels of score. The outcome highlighted that applications of this integration have been identified in various skin pathologies and in quality control, both in eHealth and mHealth. Many of these applications are based on Apps used by citizens in mHealth for self-care with new opportunities but also open questions. A generalized enthusiasm has been registered regarding the opportunities and general perspectives on improving the quality of care, optimizing the healthcare processes, minimizing costs, reducing the stress in the healthcare facilities, and in making citizens, now at the center, more satisfied. However, critical issues have emerged related to: (a) the need to improve the process of diffusion of the Apps in the hands of citizens, with better design, validation, standardization, and cybersecurity; (b) the need for better attention paid to medico-legal and ethical issues; and (c) the need for the stabilization of international and national regulations. Targeted agreement initiatives, such as position statements, guidelines, and/or consensus initiatives, are needed to ensure a better result for all, along with the design of both specific plans and shared workflows.
Collapse
|
38
|
Challenging Patterns of Atypical Dermatofibromas and Promising Diagnostic Tools for Differential Diagnosis of Malignant Lesions. Diagnostics (Basel) 2023; 13:diagnostics13040671. [PMID: 36832159 PMCID: PMC9955442 DOI: 10.3390/diagnostics13040671] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 02/07/2023] [Accepted: 02/08/2023] [Indexed: 02/15/2023] Open
Abstract
Dermatofibroma (DF) or fibrous histiocytoma is one of the most frequent benign cutaneous soft-tissue lesions, characterized by a post-inflammatory tissue reaction associated with fibrosis of the dermis. Clinically DFs have a polymorphous clinical aspect from the solitary, firm, single nodules to multiple papules with a relatively smooth surface. However, multiple atypical clinicopathological variants of DFs have been reported and, therefore, clinical recognition may become challenging, leading to a more burdensome identification and sometimes to misdiagnosis. Dermoscopy is considered an important tool in DFs diagnosis, as it improves diagnostic accuracy for clinically amelanotic nodules. Although typical dermoscopic patterns are most frequently seen in clinical practice, there have also been some atypical variants described, mimicking some underlying recurrent and sometimes harmful skin afflictions. Usually, no treatment is required, although an appropriate work-up may be necessary in specific cases, such as in the presence of atypical variants or a history of recent changes. This narrative review's aim is to summarize current evidence regarding clinical presentation, positive and differential diagnosis of atypical dermatofibromas and also to raise awareness about the importance of specific characteristics of atypical variants to better differentiate them from malignant conditions.
Collapse
|
39
|
Sun T, Niu X, He Q, Chen F, Qi RQ. Artificial Intelligence in microbiomes analysis: A review of applications in dermatology. Front Microbiol 2023; 14:1112010. [PMID: 36819026 PMCID: PMC9929457 DOI: 10.3389/fmicb.2023.1112010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 01/05/2023] [Indexed: 02/04/2023] Open
Abstract
Microorganisms are closely related to skin diseases, and microbiological imbalances or invasions of exogenous pathogens can be a source of various skin diseases. The development and prognosis of such skin diseases are also closely related to the type and composition ratio of microorganisms present. Therefore, through detection of the characteristics and changes in microorganisms, the possibility for diagnosis and prediction of skin diseases can be markedly improved. The abundance of microorganisms and an understanding of the vast amount of biological information associated with these microorganisms has been a formidable task. However, with advances in large-scale sequencing, artificial intelligence (AI)-related machine learning can serve as a means to analyze large-scales of data related to microorganisms along with determinations regarding the type and status of diseases. In this review, we describe some uses of this exciting, new emerging field. In specific, we described the recognition of fungi with convolutional neural networks (CNN), the combined application of microbial genome sequencing and machine learning and applications of AI in the diagnosis of skin diseases as related to the gut-skin axis.
Collapse
Affiliation(s)
- Te Sun
- Department of Dermatology, The First Hospital of China Medical University, Shenyang, China,Key Laboratory of Immunodermatology, Ministry of Education and NHC, National Joint Engineering Research Center for Theranostics of Immunological Skin Diseases, Shenyang, China
| | - Xueli Niu
- Department of Dermatology, The First Hospital of China Medical University, Shenyang, China,Key Laboratory of Immunodermatology, Ministry of Education and NHC, National Joint Engineering Research Center for Theranostics of Immunological Skin Diseases, Shenyang, China
| | - Qing He
- Department of Dermatology, The First Hospital of China Medical University, Shenyang, China,Key Laboratory of Immunodermatology, Ministry of Education and NHC, National Joint Engineering Research Center for Theranostics of Immunological Skin Diseases, Shenyang, China
| | - Fujun Chen
- Liaoning Center for Drug Evaluation and Inspection, Shenyang, China,*Correspondence: Fujun Chen,
| | - Rui-Qun Qi
- Department of Dermatology, The First Hospital of China Medical University, Shenyang, China,Key Laboratory of Immunodermatology, Ministry of Education and NHC, National Joint Engineering Research Center for Theranostics of Immunological Skin Diseases, Shenyang, China,Rui-Qun Qi,
| |
Collapse
|